Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Biedermann, P., Banda, J. M., Burn, E., Casajust, P., Fister, K., Hardin, J., Hester, L., Hripcsak, G., Kaas-Hansen, B. S., Khosla, S., Kolovos, S., Lynch, K. E., Makadia, R., Mehta, P. P., Morales, D. R., Morgan-Stewart, H., Mosseveld, M., Newby, D., Nyberg, F., Ostropolets, A., Woong Park, R., Prats-Uribe, A., Rao, G. A., Reich, C., Rijnbeek, P., Sena, A. G., Shoaibi, A., Spotnitz, M., Subbian, V., Suchard, M. A., Vizcaya, D., Wen, H., Wilde, M. d., Xie, J., You, S. C., Zhang, L., Lovestone, S., Ryan, P., Prieto-Alhambra, D., & , (2021). risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology, 60, 3222–3234. http://access.bl.uk/ark:/81055/vdc_100133921132.0x00001b